| A | B | C | D | E | F | G | H | I | J | K | L | M | N | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ||||||||||||||
| 2 | Brand | Indication | Economics | MOA | Approved | IP | Price JPY | 4150 | ||||||
| 3 | Savaysa/Lixiana (edoxaban) | Shares | 1917.034606 | Q422 | ||||||||||
| 4 | Tarlige (mirogabalin) | Pain | MC JPY | 7955.693614899999 | ||||||||||
| 5 | Pralia (denosumab) | Osteoporosis | AMGN | Cash JPY | 943.3729999999999 | Q222 | ||||||||
| 6 | Efient (prasugrel) | Debt JPY | 163.36700000000002 | Q222 | ||||||||||
| 7 | Tenelia (teneligliptin) | T2D | EV JPY | 7175.6876149 | ||||||||||
| 8 | Phase |